Literature DB >> 23402926

Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.

Katrin Kollmann1, Kristiina Uusi-Rauva, Enzo Scifo, Jaana Tyynelä, Anu Jalanko, Thomas Braulke.   

Abstract

Neuronal ceroid lipofuscinoses (NCL) comprise a group of inherited lysosomal disorders with variable age of onset, characterized by lysosomal accumulation of autofluorescent ceroid lipopigments, neuroinflammation, photoreceptor- and neurodegeneration. Most of the NCL-related genes encode soluble and transmembrane proteins which localize to the endoplasmic reticulum or to the endosomal/lysosomal compartment and directly or indirectly regulate lysosomal function. Recently, exome sequencing led to the identification of four novel gene defects in NCL patients and a new NCL nomenclature currently comprising CLN1 through CLN14. Although the precise function of most of the NCL proteins remains elusive, comprehensive analyses of model organisms, particularly mouse models, provided new insight into pathogenic mechanisms of NCL diseases and roles of mutant NCL proteins in cellular/subcellular protein and lipid homeostasis, as well as their adaptive/compensatorial regulation at the transcriptional level. This review summarizes the current knowledge on the expression, function and regulation of NCL proteins and their impact on lysosomal integrity. This article is part of a Special Issue entitled: The Neuronal Ceroid Lipofuscinoses or Batten Disease.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CSPα; Lysosomal storage disorder; Lysosome; Mannose 6-phosphate; Neurodegeneration; Progranulin

Mesh:

Substances:

Year:  2013        PMID: 23402926     DOI: 10.1016/j.bbadis.2013.01.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

1.  Prospects for stem cell therapy in neuronal ceroid lipofuscinosis.

Authors:  Michael C Kruer; David A Pearce; Paul J Orchard; Robert D Steiner
Journal:  Regen Med       Date:  2013-09       Impact factor: 3.806

2.  Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.

Authors:  Uma Chandrachud; Mathew W Walker; Alexandra M Simas; Sasja Heetveld; Anton Petcherski; Madeleine Klein; Hyejin Oh; Pavlina Wolf; Wen-Ning Zhao; Stephanie Norton; Stephen J Haggarty; Emyr Lloyd-Evans; Susan L Cotman
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

3.  Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.

Authors:  Carolina Courage; Karen L Oliver; Eon Joo Park; Jillian M Cameron; Kariona A Grabińska; Mikko Muona; Laura Canafoglia; Antonio Gambardella; Edith Said; Zaid Afawi; Betul Baykan; Christian Brandt; Carlo di Bonaventura; Hui Bein Chew; Chiara Criscuolo; Leanne M Dibbens; Barbara Castellotti; Patrizia Riguzzi; Angelo Labate; Alessandro Filla; Anna T Giallonardo; Geza Berecki; Christopher B Jackson; Tarja Joensuu; John A Damiano; Sara Kivity; Amos Korczyn; Aarno Palotie; Pasquale Striano; Davide Uccellini; Loretta Giuliano; Eva Andermann; Ingrid E Scheffer; Roberto Michelucci; Melanie Bahlo; Silvana Franceschetti; William C Sessa; Samuel F Berkovic; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2021-04-01       Impact factor: 11.025

4.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

5.  A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.

Authors:  Mikko Muona; Samuel F Berkovic; Leanne M Dibbens; Karen L Oliver; Snezana Maljevic; Marta A Bayly; Tarja Joensuu; Laura Canafoglia; Silvana Franceschetti; Roberto Michelucci; Salla Markkinen; Sarah E Heron; Michael S Hildebrand; Eva Andermann; Frederick Andermann; Antonio Gambardella; Paolo Tinuper; Laura Licchetta; Ingrid E Scheffer; Chiara Criscuolo; Alessandro Filla; Edoardo Ferlazzo; Jamil Ahmad; Adeel Ahmad; Betul Baykan; Edith Said; Meral Topcu; Patrizia Riguzzi; Mary D King; Cigdem Ozkara; Danielle M Andrade; Bernt A Engelsen; Arielle Crespel; Matthias Lindenau; Ebba Lohmann; Veronica Saletti; João Massano; Michael Privitera; Alberto J Espay; Birgit Kauffmann; Michael Duchowny; Rikke S Møller; Rachel Straussberg; Zaid Afawi; Bruria Ben-Zeev; Kaitlin E Samocha; Mark J Daly; Steven Petrou; Holger Lerche; Aarno Palotie; Anna-Elina Lehesjoki
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

6.  Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking.

Authors:  Carolin Schmidtke; Stephan Tiede; Melanie Thelen; Reijo Käkelä; Sabrina Jabs; Georgia Makrypidi; Marc Sylvester; Michaela Schweizer; Ingke Braren; Nahal Brocke-Ahmadinejad; Susan L Cotman; Angela Schulz; Volkmar Gieselmann; Thomas Braulke
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

7.  Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.

Authors:  Sophia-Martha Kleine Holthaus; Mikel Aristorena; Ryea Maswood; Olha Semenyuk; Justin Hoke; Aura Hare; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Hum Gene Ther       Date:  2020-07       Impact factor: 5.695

Review 8.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

9.  Prevention of Photoreceptor Cell Loss in a Cln6nclf Mouse Model of Batten Disease Requires CLN6 Gene Transfer to Bipolar Cells.

Authors:  Sophia-Martha Kleine Holthaus; Joana Ribeiro; Laura Abelleira-Hervas; Rachael A Pearson; Yanai Duran; Anastasios Georgiadis; Robert D Sampson; Matteo Rizzi; Justin Hoke; Ryea Maswood; Selina Azam; Ulrich F O Luhmann; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Mol Ther       Date:  2018-03-02       Impact factor: 11.454

Review 10.  Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).

Authors:  Nihar Kinarivala; Paul C Trippier
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.